Vectormune HVT NDV from Ceva Animal Health contains a genetically engineered Marek’s disease virus of serotype 3 expressing a key protective antigen of Newcastle disease virus. This Marek’s disease vaccine is presented in a frozen cell-associated form. Vectormune HVT NDV is recommended for in-ovo administration in 18 to 19-day-old embryonated chicken eggs and for subcutaneous administration in day-old chicks.

Fill out the form below to request more information about Ceva Animal Health Vectormune HVT NDV vaccine